It has been implicated ICOSLG as as a predictor and therapeutic target in acute lymphoblastic leukemia, and can promote the progression of glioblastoma by mediating the regulatory T-cell expansion [87, 88]. The gene discussed is ICOSLG; the disease is acute lymphoblastic leukemia.